Danaher Co. (NYSE:DHR) Shares Sold by Waterloo Capital L.P.

Waterloo Capital L.P. decreased its position in Danaher Co. (NYSE:DHR) by 32.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,754 shares of the conglomerate’s stock after selling 1,795 shares during the quarter. Waterloo Capital L.P.’s holdings in Danaher were worth $862,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher during the 4th quarter worth about $31,000. Golden State Wealth Management LLC purchased a new stake in Danaher during the 4th quarter worth about $31,000. Strategic Financial Concepts LLC acquired a new position in shares of Danaher during the 4th quarter worth about $31,000. Finally, Pineridge Advisors LLC increased its holdings in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is owned by corporate insiders.

Danaher Stock Down 8.3 %

Shares of NYSE:DHR opened at $181.42 on Monday. Danaher Co. has a fifty-two week low of $165.17 and a fifty-two week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm’s 50-day simple moving average is $209.99 and its 200-day simple moving average is $233.73. The company has a market cap of $129.66 billion, a price-to-earnings ratio of 34.36, a PEG ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm posted $2.09 EPS. As a group, equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.32 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.71%. Danaher’s dividend payout ratio is presently 24.24%.

Analyst Ratings Changes

DHR has been the subject of a number of research analyst reports. JPMorgan Chase & Co. lowered their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Citigroup reduced their price objective on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a research report on Friday, March 14th. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a research report on Friday, December 13th. Finally, StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Five investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $278.24.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.